What's breaking now, across thousands of outlets.
The FDA on Sept. 22 classified the recall of one lot of Vitruvias Therapeutics' 30 mg thyroid tablets as Class I, its highest risk level
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
Clinical decision-support tools have the potential to help clinicians make evidence-based decisions, access relevant patient information and navigate complex care.
Being made to feel different, lesser or unwanted can be a common experience for many minority groups. When people are excluded or denied full social acceptance because they are perceived as having a…
Lilly wagered up to $3.35 billion in its fourth China-focused alliance since January 2025. Elsewhere, analysts are now more confident about one of Vertex’s top prospects and an RNA drug succeeded…
President Donald Trump's new nominee to lead the FDA, Heidi Overton, is set to testify before senators in her confirmation hearing Thursday.
Kelly O'Grady got a first look at Neko Health's more affordable full-body health scan. She did the scan, which found something in her bloodwork that put her on alert.
